A STEADY-STATE EVALUATION OF THE EFFECTS OF PROPANTHELINE BROMIDE AND CHOLESTYRAMINE ON THE BIOAVAILABILITY OF DIGOXIN WHEN ADMINISTERED AS TABLETS OR CAPSULES

被引：25

作者：

BROWN, DD ^{[1
]}

SCHMID, J ^{[1
]}

LONG, RA ^{[1
]}

HULL, JH ^{[1
]}

机构：

[1] BURROUGHS WELLCOME CO, DEPT CLIN RES, RES TRIANGLE PK, NC 27709 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 25卷 / 05期

关键词：

D O I：

10.1002/j.1552-4604.1985.tb02855.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：360 / 364

页数：5

共 15 条

[1] EFFECT OF MAGNESIUM-ALUMINUM HYDROXIDE AND KAOLIN-PECTIN ON ABSORPTION OF DIGOXIN FROM TABLETS AND CAPSULES [J].

ALLEN, MD ;

GREENBLATT, DJ ;

HARMATZ, JS ;

SMITH, TW .

JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (01) :26-30

[2]

[Anonymous], 1977, J AM PHARM ASSOC, V17, P635

[3]

BINNION PF, 1976, J CLIN PHARMACOL, V16, P461

[4]

BROWN DD, 1979, CLIN RES, V27, pA610

[5] DECREASED BIOAVAILABILITY OF DIGOXIN DUE TO ANTACIDS AND KAOLIN-PECTIN [J].

BROWN, DD ;

JUHL, RP .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (19) :1034-1037

[6] DECREASED BIOAVAILABILITY OF DIGOXIN DUE TO HYPOCHOLESTEROLEMIC INTERVENTIONS [J].

BROWN, DD ;

JUHL, RP ;

WARNER, SL .

CIRCULATION, 1978, 58 (01) :164-172

[7] DRUG-INTERACTIONS WITH DIGOXIN [J].

BROWN, DD ;

SPECTOR, R ;

JUHL, RP .

DRUGS, 1980, 20 (03) :198-206

[8]

HUFFMAN DH, 1974, CLIN PHARMACOL THER, V16, P310

[9]

JOHNSON BF, 1976, CLIN PHARMACOL THER, V19, P746

[10]

JOHNSON BF, 1975, BRIT HEART J, V37, P203

← 1 2 →